BWV Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Benzinga - Mentions: BIOR GH AVGR SYRS ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

2 years ago - By: Benzinga - Mentions: BMRA LNTH CKPT ARQT ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

2 years ago - By: Onconetix, Inc.

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

2 years ago - By: Onconetix, Inc.

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Issues Letter to Shareholders

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

2 years ago - By: InvestorPlace - Mentions: OLIT ENGN LMDX QLTA ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Seeking Alpha

Blue Water to acquire a commercial stage oncology company (NASDAQ:BWV)

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

2 years ago - By: InvestorPlace - Mentions: LMDX AKU HARP TGH ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

2 years ago - By: Seeking Alpha

Blue Water Biotech to build copay assistance programs for its products (NASDAQ:BWV)

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

2 years ago - By: Blue Water Biotech, Inc.

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

2 years ago - By: Blue Water Biotech, Inc.

BLUE WATER BIOTECH INC (BWV) Stock News

BWV Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Blue Water Biotech Issues Letter to Shareholders

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Blue Water to acquire a commercial stage oncology company (NASDAQ:BWV)

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Blue Water Biotech to build copay assistance programs for its products (NASDAQ:BWV)

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio